Dynamics and turnover of memory CD8 T cell responses following yellow fever vaccination
Zarnitsyna, V. I.; Akondy, R. S.; Ahmed, H.; McGuire, D. J.; Zarnitsyn, V. G.; Moore, M.; Johnson, P. L. F.; Ahmed, R.; Li, K.; Hellerstein, M.; Antia, R.
Show abstract
Understanding how immunological memory lasts a lifetime requires quantifying changes in the number of memory cells as well as how their division and death rates change over time. We address these questions by using a statistically powerful mixed-effects differential equations framework to analyze data from two human studies that follow CD8 T cell responses to the yellow fever vaccine (YFV-17D). Models were first fit to the frequency and division rates of YFV-specific memory CD8 T cells 42 days to 1 year post-vaccination. A different dataset, on the loss of YFV-specific CD8 T cells over three decades, was used to assess out of sample predictions of our models. The commonly used exponential and bi-exponential decline models performed relatively poorly. Models with the cell loss following a power law (exactly or approximately) were most predictive. Notably, using only the first year of data, these models accurately predicted T cell frequencies up to 30 years post-vaccination. Our analyses suggest that division rates of these cells drop and plateau at a low level (0.001 per day, ~double estimates for naive T cells) within one year following vaccination, whereas death rates continue to decline for much longer. Our results show that power laws can be predictive for T cell memory, a finding that may be useful for vaccine evaluation and epidemiological modeling. Moreover, since power laws asymptotically decline more slowly than any exponential decline, our results help explain the longevity of immune memory phenomenologically. Author summaryImmunological memory, generated in response to infection or vaccination, may provide complete or partial protection from antigenically similar infections for the lifetime. Memory CD8 T cells are important players in protection from secondary viral infections but quantitative understanding of their dynamics in humans is limited. We analyze data from two studies where immunization with the yellow fever virus vaccine (YFV-17D) generates a mild acute infection and long-term memory. We find that: (i) the division rate of YFV-17D-specific CD8 T cells drops and stabilizes at ~ 0.1% per day during the first year following vaccination whereas the death rate declines more gradually, and (ii) the number of these cells declines approximately in accordance with a power law ({propto}time-0.82) for at least several decades following vaccination.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement 94%
- Beyond the new normal: assessing the feasibility of vaccine-based elimination of SARS-CoV-2 94%
- Modeling the effect of vaccination strategies in an Excel spreadsheet: The rate of vaccination, and not only the vaccination coverage, is a determinant for containing COVID-19 in urban areas 93%
Similar papers in this journal
- Mathematical modeling indicates that regulatory inhibition of CD8+ T cell cytotoxicity can limit efficacy of IL-15 immunotherapy in cases of high pre-treatment SIV viral load 94%
- The relative contributions of infectious and mitotic spread to HTLV-1 persistence 93%
- Evaluation of CD8 T cell killing models with computer simulations of 2-photon imaging experiments 93%
Similar papers in this journal
- Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19 93%
- Interpreting vaccine efficacy trial results for infection and transmission 93%
- Resource Allocation for Different Types of Vaccines against COVID-19: Tradeoffs and Synergies between Efficacy and Reach 93%
Similar papers in this journal
- Multi-strain modeling of influenza vaccine effectiveness in older adults and its dependence on antigenic distance 93%
- Importance of epidemic severity and vaccine mode of action and availability for delaying the second vaccine dose 93%
- Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2: toward universal blueprints for vaccine designs 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.